TELO vs TSLA · $86.0M cap vs P/E 179, rev $28.24B
Telomir Pharmaceuticals, Inc. Common Stock (TELO) versus Tesla Inc (TSLA) — a side-by-side from cached financials, not a winner call.
Telomir Pharmaceuticals, Inc. Common Stock (TELO) is a biotechnology company listed on NASDAQ.
Tesla Inc (TSLA) is a auto manufacturers company listed on US. It is led by Elon Musk.
TELO does not have a complete income-statement cache yet.
Latest reported TSLA revenue for 2026-06-30 was $28.24B. Net income was $1.11B. Revenue was up 26.1% from 2026-03-31 to 2026-06-30. TSLA currently screens at market cap $976.12B and trailing P/E 179.1.
TELO currently screens at market cap $86.0M. TSLA currently screens at market cap $976.12B and trailing P/E 179.1.
Not investment advice. Open the TELO and TSLA stock pages for the full models.
Not investment advice.